Paclitaxel-loaded, Curcumin modified Graphene/PLA-PEG Nanoparticles as a potential Chemo-Photothermal treatment of aggressive tumours
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00531d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Andreas Mouikis und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The combination of chemotherapy and photothermal therapy are effective tools against aggressive desmoplastic cancers, including PDAC and metastatic prostate cancer. Graphene nanomaterials are investigated for combined chemo-photothermal cancer treatment due...
Zitieren
APA
Mouikis, A., Angelopoulou, A., Kolokithas-Ntoukas, A., Xanthopoulos, S., Polakova, K., Riabonenko, O., Georgakilas, V. I., Bouziotis, P., & Avgoustakis, K. (2026). Paclitaxel-loaded, Curcumin modified Graphene/PLA-PEG Nanoparticles as a potential Chemo-Photothermal treatment of aggressive tumours. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00531d
Vancouver
Mouikis A, Angelopoulou A, Kolokithas-Ntoukas A, Xanthopoulos S, Polakova K, Riabonenko O, et al. Paclitaxel-loaded, Curcumin modified Graphene/PLA-PEG Nanoparticles as a potential Chemo-Photothermal treatment of aggressive tumours. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00531d
BibTeX
@article{Mouikis2026,
author = {Mouikis, Andreas and Angelopoulou, Athina and Kolokithas-Ntoukas, Argiris and Xanthopoulos, Stavros and Polakova, Katerina and Riabonenko, Oleksandr and Georgakilas, Vasilios I and Bouziotis, Penelope and Avgoustakis, Konstantinos},
title = {Paclitaxel-loaded, Curcumin modified Graphene/PLA-PEG Nanoparticles as a potential Chemo-Photothermal treatment of aggressive tumours},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00531d}
}
EUVIMED